Skip to content
Biodatica
Start free

Investigator

Seth Lawler Shipman

J. DAVID GLADSTONE INSTITUTES · funded by NIAID, NIA

Companies
5

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$4.5M

Summed across those awards.

First award
Jun 17, 2025

Latest May 11, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P01

    Admin Core

    $380k

    May 11, 2026NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11265553 (opens the source filing in a new tab)

  2. P01

    High-Throughput Assays for Direct Comparison of Recognition and Entry via Natural and Engineered Receptor Binding Proteins

    $505k

    May 11, 2026NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11265556 (opens the source filing in a new tab)

  3. P01

    PhAIge Therapy Center: AI-Guided Tailspike Engineering and Molecular Typing for Rapid Phage Design and Testing Against ESKAPE Pathogens

    $2.0M

    May 11, 2026NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11265552 (opens the source filing in a new tab)

  4. R01

    Mitochondrial DNA Compaction and the Accumulation of Mutations with Age and Stress

    $794k

    Jun 17, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11104126 (opens the source filing in a new tab)

  5. R01

    Mitochondrial DNA Compaction and the Accumulation of Mutations with Age and Stress

    $794k

    Jun 17, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11357639 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources